Global Systemic Mastocytosis Treatment Market 2025-2029

Publisher TechNavio

Published Jun 18, 2025

Length 214 Pages

SKU # INF20137360

Description

Systemic Mastocytosis Treatment Market 2025-2029

The systemic mastocytosis treatment market is forecasted to grow by USD 173.8 mn during 2024-2029, accelerating at a CAGR of 6.5% during the forecast period. The report on the systemic mastocytosis treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growth of aging population, increasing prevalence of blood cancer, and growing healthcare expenditure.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's systemic mastocytosis treatment market is segmented as below:

By Type

AK-002
BLU-285
Brentuximab vedotin
Crenolanib besylate
Others

By Route Of Administration

Oral
Injectables
Topical

By End-user

Hospitals
Specialty clinics
Research and academic institutes
Others

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the advancements in diagnostic technologies for systemic mastocytosis management as one of the prime reasons driving the systemic mastocytosis treatment market growth during the next few years. Also, development of new drugs for systemic mastocytosis treatment and growing adoption of targeted therapies for systemic mastocytosis treatment will lead to sizable demand in the market.

The report on the systemic mastocytosis treatment market covers the following areas:

Systemic Mastocytosis Treatment Market sizing
Systemic Mastocytosis Treatment Market forecast
Systemic Mastocytosis Treatment Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading systemic mastocytosis treatment market vendors that include AB Science SA, AdvaCare Pharma, Cogent Biosciences, Inc., Dr Reddys Laboratories Ltd., Glenmark Pharmaceuticals Ltd., Lupin Ltd., Novartis AG, Pfizer Inc., and Sanofi SA. Also, the systemic mastocytosis treatment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary: 1.1 Market overview; Executive Summary - Chart on Market Overview; Executive Summary - Data Table on Market Overview; Executive Summary - Chart on Global Market Characteristics; Executive Summary - Chart on Market By Geographical Landscape; Executive Summary - Chart on Market Segmentation by Type; Executive Summary - Chart on Market Segmentation by Route of Administration; Executive Summary - Chart on Market Segmentation by End-user; Executive Summary - Chart on Incremental Growth; Executive Summary - Data Table on Incremental Growth; Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis: 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; 2.2 Criticality of inputs and Factors of differentiation; Overview on criticality of inputs and factors of differentiation; 2.3 Factors of disruption; Overview on factors of disruption; 2.4 Impact of drivers and challenges; Impact of drivers and challenges in 2024 and 2029
3 Market Landscape: 3.1 Market ecosystem; Parent Market; Data Table on - Parent Market; 3.2 Market characteristics; Market characteristics analysis; 3.3 Value chain analysis; Value chain analysis
4 Market Sizing: 4.1 Market definition; Offerings of companies included in the market definition; 4.2 Market segment analysis; Market segments; 4.3 Market size 2024; 4.4 Market outlook: Forecast for 2024-2029; Chart on Global - Market size and forecast 2024-2029 ($ million); Data Table on Global - Market size and forecast 2024-2029 ($ million); Chart on Global Market: Year-over-year growth 2024-2029 (%); Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size: 5.1 Global Systemic Mastocytosis Treatment Market 2019 - 2023; Historic Market Size - Data Table on Global Systemic Mastocytosis Treatment Market 2019 - 2023 ($ million); 5.2 Type segment analysis 2019 - 2023; Historic Market Size - Type Segment 2019 - 2023 ($ million); 5.3 Route of Administration segment analysis 2019 - 2023; Historic Market Size - Route of Administration Segment 2019 - 2023 ($ million); 5.4 End-user segment analysis 2019 - 2023; Historic Market Size - End-user Segment 2019 - 2023 ($ million); 5.5 Geography segment analysis 2019 - 2023; Historic Market Size - Geography Segment 2019 - 2023 ($ million); 5.6 Country segment analysis 2019 - 2023; Historic Market Size - Country Segment 2019 - 2023 ($ million)
6 Qualitative Analysis: 6.1 The AI impact on global systemic mastocytosis treatment market
7 Five Forces Analysis: 7.1 Five forces summary; Five forces analysis - Comparison between 2024 and 2029; 7.2 Bargaining power of buyers; Bargaining power of buyers - Impact of key factors 2024 and 2029; 7.3 Bargaining power of suppliers; Bargaining power of suppliers - Impact of key factors in 2024 and 2029; 7.4 Threat of new entrants; Threat of new entrants - Impact of key factors in 2024 and 2029; 7.5 Threat of substitutes; Threat of substitutes - Impact of key factors in 2024 and 2029; 7.6 Threat of rivalry; Threat of rivalry - Impact of key factors in 2024 and 2029; 7.7 Market condition; Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Type: 8.1 Market segments; Chart on Type - Market share 2024-2029 (%); Data Table on Type - Market share 2024-2029 (%); 8.2 Comparison by Type; Chart on Comparison by Type; Data Table on Comparison by Type; 8.3 AK-002 - Market size and forecast 2024-2029; Chart on AK-002 - Market size and forecast 2024-2029 ($ million); Data Table on AK-002 - Market size and forecast 2024-2029 ($ million); Chart on AK-002 - Year-over-year growth 2024-2029 (%); Data Table on AK-002 - Year-over-year growth 2024-2029 (%); 8.4 BLU-285 - Market size and forecast 2024-2029; Chart on BLU-285 - Market size and forecast 2024-2029 ($ million); Data Table on BLU-285 - Market size and forecast 2024-2029 ($ million); Chart on BLU-285 - Year-over-year growth 2024-2029 (%); Data Table on BLU-285 - Year-over-year growth 2024-2029 (%); 8.5 Brentuximab vedotin - Market size and forecast 2024-2029; Chart on Brentuximab vedotin - Market size and forecast 2024-2029 ($ million); Data Table on Brentuximab vedotin - Market size and forecast 2024-2029 ($ million); Chart on Brentuximab vedotin - Year-over-year growth 2024-2029 (%); Data Table on Brentuximab vedotin - Year-over-year growth 2024-2029 (%); 8.6 Crenolanib besylate - Market size and forecast 2024-2029; Chart on Crenolanib besylate - Market size and forecast 2024-2029 ($ million); Data Table on Crenolanib besylate - Market size and forecast 2024-2029 ($ million); Chart on Crenolanib besylate - Year-over-year growth 2024-2029 (%); Data Table on Crenolanib besylate - Year-over-year growth 2024-2029 (%); 8.7 Others - Market size and forecast 2024-2029; Chart on Others - Market size and forecast 2024-2029 ($ million); Data Table on Others - Market size and forecast 2024-2029 ($ million); Chart on Others - Year-over-year growth 2024-2029 (%); Data Table on Others - Year-over-year growth 2024-2029 (%); 8.8 Market opportunity by Type; Market opportunity by Type ($ million); Data Table on Market opportunity by Type ($ million)
9 Market Segmentation by Route of Administration: 9.1 Market segments; Chart on Route of Administration - Market share 2024-2029 (%); Data Table on Route of Administration - Market share 2024-2029 (%); 9.2 Comparison by Route of Administration; Chart on Comparison by Route of Administration; Data Table on Comparison by Route of Administration; 9.3 Oral - Market size and forecast 2024-2029; Chart on Oral - Market size and forecast 2024-2029 ($ million); Data Table on Oral - Market size and forecast 2024-2029 ($ million); Chart on Oral - Year-over-year growth 2024-2029 (%); Data Table on Oral - Year-over-year growth 2024-2029 (%); 9.4 Injectables - Market size and forecast 2024-2029; Chart on Injectables - Market size and forecast 2024-2029 ($ million); Data Table on Injectables - Market size and forecast 2024-2029 ($ million); Chart on Injectables - Year-over-year growth 2024-2029 (%); Data Table on Injectables - Year-over-year growth 2024-2029 (%); 9.5 Topical - Market size and forecast 2024-2029; Chart on Topical - Market size and forecast 2024-2029 ($ million); Data Table on Topical - Market size and forecast 2024-2029 ($ million); Chart on Topical - Year-over-year growth 2024-2029 (%); Data Table on Topical - Year-over-year growth 2024-2029 (%); 9.6 Market opportunity by Route of Administration; Market opportunity by Route of Administration ($ million); Data Table on Market opportunity by Route of Administration ($ million)
10 Market Segmentation by End-user: 10.1 Market segments; Chart on End-user - Market share 2024-2029 (%); Data Table on End-user - Market share 2024-2029 (%); 10.2 Comparison by End-user; Chart on Comparison by End-user; Data Table on Comparison by End-user; 10.3 Hospitals - Market size and forecast 2024-2029; Chart on Hospitals - Market size and forecast 2024-2029 ($ million); Data Table on Hospitals - Market size and forecast 2024-2029 ($ million); Chart on Hospitals - Year-over-year growth 2024-2029 (%); Data Table on Hospitals - Year-over-year growth 2024-2029 (%); 10.4 Specialty clinics - Market size and forecast 2024-2029; Chart on Specialty clinics - Market size and forecast 2024-2029 ($ million); Data Table on Specialty clinics - Market size and forecast 2024-2029 ($ million); Chart on Specialty clinics - Year-over-year growth 2024-2029 (%); Data Table on Specialty clinics - Year-over-year growth 2024-2029 (%); 10.5 Research and academic institutes - Market size and forecast 2024-2029; Chart on Research and academic institutes - Market size and forecast 2024-2029 ($ million); Data Table on Research and academic institutes - Market size and forecast 2024-2029 ($ million); Chart on Research and academic institutes - Year-over-year growth 2024-2029 (%); Data Table on Research and academic institutes - Year-over-year growth 2024-2029 (%); 10.6 Others - Market size and forecast 2024-2029; Chart on Others - Market size and forecast 2024-2029 ($ million); Data Table on Others - Market size and forecast 2024-2029 ($ million); Chart on Others - Year-over-year growth 2024-2029 (%); Data Table on Others - Year-over-year growth 2024-2029 (%); 10.7 Market opportunity by End-user; Market opportunity by End-user ($ million); Data Table on Market opportunity by End-user ($ million)
11 Customer Landscape: 11.1 Customer landscape overview; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape: 12.1 Geographic segmentation; Chart on Market share By Geographical Landscape 2024-2029 (%); Data Table on Market share By Geographical Landscape 2024-2029 (%); 12.2 Geographic comparison; Chart on Geographic comparison; Data Table on Geographic comparison; 12.3 North America - Market size and forecast 2024-2029; Chart on North America - Market size and forecast 2024-2029 ($ million); Data Table on North America - Market size and forecast 2024-2029 ($ million); Chart on North America - Year-over-year growth 2024-2029 (%); Data Table on North America - Year-over-year growth 2024-2029 (%); 12.4 Europe - Market size and forecast 2024-2029; Chart on Europe - Market size and forecast 2024-2029 ($ million); Data Table on Europe - Market size and forecast 2024-2029 ($ million); Chart on Europe - Year-over-year growth 2024-2029 (%); Data Table on Europe - Year-over-year growth 2024-2029 (%); 12.5 Asia - Market size and forecast 2024-2029; Chart on Asia - Market size and forecast 2024-2029 ($ million); Data Table on Asia - Market size and forecast 2024-2029 ($ million); Chart on Asia - Year-over-year growth 2024-2029 (%); Data Table on Asia - Year-over-year growth 2024-2029 (%); 12.6 Rest of World (ROW) - Market size and forecast 2024-2029; Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million); Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million); Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%); Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%); 12.7 US - Market size and forecast 2024-2029; Chart on US - Market size and forecast 2024-2029 ($ million); Data Table on US - Market size and forecast 2024-2029 ($ million); Chart on US - Year-over-year growth 2024-2029 (%); Data Table on US - Year-over-year growth 2024-2029 (%); 12.8 China - Market size and forecast 2024-2029; Chart on China - Market size and forecast 2024-2029 ($ million); Data Table on China - Market size and forecast 2024-2029 ($ million); Chart on China - Year-over-year growth 2024-2029 (%); Data Table on China - Year-over-year growth 2024-2029 (%); 12.9 Canada - Market size and forecast 2024-2029; Chart on Canada - Market size and forecast 2024-2029 ($ million); Data Table on Canada - Market size and forecast 2024-2029 ($ million); Chart on Canada - Year-over-year growth 2024-2029 (%); Data Table on Canada - Year-over-year growth 2024-2029 (%); 12.10 Germany - Market size and forecast 2024-2029; Chart on Germany - Market size and forecast 2024-2029 ($ million); Data Table on Germany - Market size and forecast 2024-2029 ($ million); Chart on Germany - Year-over-year growth 2024-2029 (%); Data Table on Germany - Year-over-year growth 2024-2029 (%); 12.11 Japan - Market size and forecast 2024-2029; Chart on Japan - Market size and forecast 2024-2029 ($ million); Data Table on Japan - Market size and forecast 2024-2029 ($ million); Chart on Japan - Year-over-year growth 2024-2029 (%); Data Table on Japan - Year-over-year growth 2024-2029 (%); 12.12 UK - Market size and forecast 2024-2029; Chart on UK - Market size and forecast 2024-2029 ($ million); Data Table on UK - Market size and forecast 2024-2029 ($ million); Chart on UK - Year-over-year growth 2024-2029 (%); Data Table on UK - Year-over-year growth 2024-2029 (%); 12.13 France - Market size and forecast 2024-2029; Chart on France - Market size and forecast 2024-2029 ($ million); Data Table on France - Market size and forecast 2024-2029 ($ million); Chart on France - Year-over-year growth 2024-2029 (%); Data Table on France - Year-over-year growth 2024-2029 (%); 12.14 Mexico - Market size and forecast 2024-2029; Chart on Mexico - Market size and forecast 2024-2029 ($ million); Data Table on Mexico - Market size and forecast 2024-2029 ($ million); Chart on Mexico - Year-over-year growth 2024-2029 (%); Data Table on Mexico - Year-over-year growth 2024-2029 (%); 12.15 Italy - Market size and forecast 2024-2029; Chart on Italy - Market size and forecast 2024-2029 ($ million); Data Table on Italy - Market size and forecast 2024-2029 ($ million); Chart on Italy - Year-over-year growth 2024-2029 (%); Data Table on Italy - Year-over-year growth 2024-2029 (%); 12.16 India - Market size and forecast 2024-2029; Chart on India - Market size and forecast 2024-2029 ($ million); Data Table on India - Market size and forecast 2024-2029 ($ million); Chart on India - Year-over-year growth 2024-2029 (%); Data Table on India - Year-over-year growth 2024-2029 (%); 12.17 Market opportunity By Geographical Landscape; Market opportunity By Geographical Landscape ($ million); Data Tables on Market opportunity By Geographical Landscape ($ million)
13 Drivers, Challenges, and Opportunity/Restraints: 13.1 Market drivers; 13.2 Market challenges; 13.3 Impact of drivers and challenges; Impact of drivers and challenges in 2024 and 2029; 13.4 Market opportunities/restraints
14 Competitive Landscape: 14.1 Overview; 14.2 Competitive Landscape; Overview on criticality of inputs and factors of differentiation; 14.3 Landscape disruption; Overview on factors of disruption; 14.4 Industry risks; Impact of key risks on business
15 Competitive Analysis: 15.1 Companies profiled; Companies covered; 15.2 Company ranking index; Company ranking index; 15.3 Market positioning of companies; Matrix on companies position and classification; 15.4 AB Science SA; AB Science SA - Overview; AB Science SA - Product / Service; AB Science SA - Key offerings; SWOT; 15.5 AdvaCare Pharma; AdvaCare Pharma - Overview; AdvaCare Pharma - Product / Service; AdvaCare Pharma - Key offerings; SWOT; 15.6 Cogent Biosciences, Inc.; Cogent Biosciences, Inc. - Overview; Cogent Biosciences, Inc. - Product / Service; Cogent Biosciences, Inc. - Key offerings; SWOT; 15.7 Dr Reddys Laboratories Ltd.; Dr Reddys Laboratories Ltd. - Overview; Dr Reddys Laboratories Ltd. - Business segments; Dr Reddys Laboratories Ltd. - Key news; Dr Reddys Laboratories Ltd. - Key offerings; Dr Reddys Laboratories Ltd. - Segment focus; SWOT; 15.8 Glenmark Pharmaceuticals Ltd.; Glenmark Pharmaceuticals Ltd. - Overview; Glenmark Pharmaceuticals Ltd. - Product / Service; Glenmark Pharmaceuticals Ltd. - Key offerings; SWOT; 15.9 Lupin Ltd.; Lupin Ltd. - Overview; Lupin Ltd. - Business segments; Lupin Ltd. - Key news; Lupin Ltd. - Key offerings; Lupin Ltd. - Segment focus; SWOT; 15.10 Novartis AG; Novartis AG - Overview; Novartis AG - Business segments; Novartis AG - Key news; Novartis AG - Key offerings; Novartis AG - Segment focus; SWOT; 15.11 Pfizer Inc.; Pfizer Inc. - Overview; Pfizer Inc. - Product / Service; Pfizer Inc. - Key news; Pfizer Inc. - Key offerings; SWOT; 15.12 Sanofi SA; Sanofi SA - Overview; Sanofi SA - Business segments; Sanofi SA - Key news; Sanofi SA - Key offerings; Sanofi SA - Segment focus; SWOT
16 Appendix: 16.1 Scope of the report; 16.2 Inclusions and exclusions checklist; Inclusions checklist; Exclusions checklist; 16.3 Currency conversion rates for US$; Currency conversion rates for US$; 16.4 Research methodology; Research methodology; 16.5 Data procurement; Information sources; 16.6 Data validation; Data validation; 16.7 Validation techniques employed for market sizing; Validation techniques employed for market sizing; 16.8 Data synthesis; Data synthesis; 16.9 360 degree market analysis; 360 degree market analysis; 16.10 List of abbreviations; List of abbreviations
Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Global Market Characteristics; Exhibits4: Executive Summary - Chart on Market By Geographical Landscape; Exhibits5: Executive Summary - Chart on Market Segmentation by Type; Exhibits6: Executive Summary - Chart on Market Segmentation by Route of Administration; Exhibits7: Executive Summary - Chart on Market Segmentation by End-user; Exhibits8: Executive Summary - Chart on Incremental Growth; Exhibits9: Executive Summary - Data Table on Incremental Growth; Exhibits10: Executive Summary - Chart on Company Market Positioning; Exhibits11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits12: Overview on criticality of inputs and factors of differentiation; Exhibits13: Overview on factors of disruption; Exhibits14: Impact of drivers and challenges in 2024 and 2029; Exhibits15: Parent Market; Exhibits16: Data Table on - Parent Market; Exhibits17: Market characteristics analysis; Exhibits18: Value chain analysis; Exhibits19: Offerings of companies included in the market definition; Exhibits20: Market segments; Exhibits21: Chart on Global - Market size and forecast 2024-2029 ($ million); Exhibits22: Data Table on Global - Market size and forecast 2024-2029 ($ million); Exhibits23: Chart on Global Market: Year-over-year growth 2024-2029 (%); Exhibits24: Data Table on Global Market: Year-over-year growth 2024-2029 (%); Exhibits25: Historic Market Size - Data Table on Global Systemic Mastocytosis Treatment Market 2019 - 2023 ($ million); Exhibits26: Historic Market Size - Type Segment 2019 - 2023 ($ million); Exhibits27: Historic Market Size - Route of Administration Segment 2019 - 2023 ($ million); Exhibits28: Historic Market Size - End-user Segment 2019 - 2023 ($ million); Exhibits29: Historic Market Size - Geography Segment 2019 - 2023 ($ million); Exhibits30: Historic Market Size - Country Segment 2019 - 2023 ($ million); Exhibits31: Five forces analysis - Comparison between 2024 and 2029; Exhibits32: Bargaining power of buyers - Impact of key factors 2024 and 2029; Exhibits33: Bargaining power of suppliers - Impact of key factors in 2024 and 2029; Exhibits34: Threat of new entrants - Impact of key factors in 2024 and 2029; Exhibits35: Threat of substitutes - Impact of key factors in 2024 and 2029; Exhibits36: Threat of rivalry - Impact of key factors in 2024 and 2029; Exhibits37: Chart on Market condition - Five forces 2024 and 2029; Exhibits38: Chart on Type - Market share 2024-2029 (%); Exhibits39: Data Table on Type - Market share 2024-2029 (%); Exhibits40: Chart on Comparison by Type; Exhibits41: Data Table on Comparison by Type; Exhibits42: Chart on AK-002 - Market size and forecast 2024-2029 ($ million); Exhibits43: Data Table on AK-002 - Market size and forecast 2024-2029 ($ million); Exhibits44: Chart on AK-002 - Year-over-year growth 2024-2029 (%); Exhibits45: Data Table on AK-002 - Year-over-year growth 2024-2029 (%); Exhibits46: Chart on BLU-285 - Market size and forecast 2024-2029 ($ million); Exhibits47: Data Table on BLU-285 - Market size and forecast 2024-2029 ($ million); Exhibits48: Chart on BLU-285 - Year-over-year growth 2024-2029 (%); Exhibits49: Data Table on BLU-285 - Year-over-year growth 2024-2029 (%); Exhibits50: Chart on Brentuximab vedotin - Market size and forecast 2024-2029 ($ million); Exhibits51: Data Table on Brentuximab vedotin - Market size and forecast 2024-2029 ($ million); Exhibits52: Chart on Brentuximab vedotin - Year-over-year growth 2024-2029 (%); Exhibits53: Data Table on Brentuximab vedotin - Year-over-year growth 2024-2029 (%); Exhibits54: Chart on Crenolanib besylate - Market size and forecast 2024-2029 ($ million); Exhibits55: Data Table on Crenolanib besylate - Market size and forecast 2024-2029 ($ million); Exhibits56: Chart on Crenolanib besylate - Year-over-year growth 2024-2029 (%); Exhibits57: Data Table on Crenolanib besylate - Year-over-year growth 2024-2029 (%); Exhibits58: Chart on Others - Market size and forecast 2024-2029 ($ million); Exhibits59: Data Table on Others - Market size and forecast 2024-2029 ($ million); Exhibits60: Chart on Others - Year-over-year growth 2024-2029 (%); Exhibits61: Data Table on Others - Year-over-year growth 2024-2029 (%); Exhibits62: Market opportunity by Type ($ million); Exhibits63: Data Table on Market opportunity by Type ($ million); Exhibits64: Chart on Route of Administration - Market share 2024-2029 (%); Exhibits65: Data Table on Route of Administration - Market share 2024-2029 (%); Exhibits66: Chart on Comparison by Route of Administration; Exhibits67: Data Table on Comparison by Route of Administration; Exhibits68: Chart on Oral - Market size and forecast 2024-2029 ($ million); Exhibits69: Data Table on Oral - Market size and forecast 2024-2029 ($ million); Exhibits70: Chart on Oral - Year-over-year growth 2024-2029 (%); Exhibits71: Data Table on Oral - Year-over-year growth 2024-2029 (%); Exhibits72: Chart on Injectables - Market size and forecast 2024-2029 ($ million); Exhibits73: Data Table on Injectables - Market size and forecast 2024-2029 ($ million); Exhibits74: Chart on Injectables - Year-over-year growth 2024-2029 (%); Exhibits75: Data Table on Injectables - Year-over-year growth 2024-2029 (%); Exhibits76: Chart on Topical - Market size and forecast 2024-2029 ($ million); Exhibits77: Data Table on Topical - Market size and forecast 2024-2029 ($ million); Exhibits78: Chart on Topical - Year-over-year growth 2024-2029 (%); Exhibits79: Data Table on Topical - Year-over-year growth 2024-2029 (%); Exhibits80: Market opportunity by Route of Administration ($ million); Exhibits81: Data Table on Market opportunity by Route of Administration ($ million); Exhibits82: Chart on End-user - Market share 2024-2029 (%); Exhibits83: Data Table on End-user - Market share 2024-2029 (%); Exhibits84: Chart on Comparison by End-user; Exhibits85: Data Table on Comparison by End-user; Exhibits86: Chart on Hospitals - Market size and forecast 2024-2029 ($ million); Exhibits87: Data Table on Hospitals - Market size and forecast 2024-2029 ($ million); Exhibits88: Chart on Hospitals - Year-over-year growth 2024-2029 (%); Exhibits89: Data Table on Hospitals - Year-over-year growth 2024-2029 (%); Exhibits90: Chart on Specialty clinics - Market size and forecast 2024-2029 ($ million); Exhibits91: Data Table on Specialty clinics - Market size and forecast 2024-2029 ($ million); Exhibits92: Chart on Specialty clinics - Year-over-year growth 2024-2029 (%); Exhibits93: Data Table on Specialty clinics - Year-over-year growth 2024-2029 (%); Exhibits94: Chart on Research and academic institutes - Market size and forecast 2024-2029 ($ million); Exhibits95: Data Table on Research and academic institutes - Market size and forecast 2024-2029 ($ million); Exhibits96: Chart on Research and academic institutes - Year-over-year growth 2024-2029 (%); Exhibits97: Data Table on Research and academic institutes - Year-over-year growth 2024-2029 (%); Exhibits98: Chart on Others - Market size and forecast 2024-2029 ($ million); Exhibits99: Data Table on Others - Market size and forecast 2024-2029 ($ million); Exhibits100: Chart on Others - Year-over-year growth 2024-2029 (%); Exhibits101: Data Table on Others - Year-over-year growth 2024-2029 (%); Exhibits102: Market opportunity by End-user ($ million); Exhibits103: Data Table on Market opportunity by End-user ($ million); Exhibits104: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits105: Chart on Market share By Geographical Landscape 2024-2029 (%); Exhibits106: Data Table on Market share By Geographical Landscape 2024-2029 (%); Exhibits107: Chart on Geographic comparison; Exhibits108: Data Table on Geographic comparison; Exhibits109: Chart on North America - Market size and forecast 2024-2029 ($ million); Exhibits110: Data Table on North America - Market size and forecast 2024-2029 ($ million); Exhibits111: Chart on North America - Year-over-year growth 2024-2029 (%); Exhibits112: Data Table on North America - Year-over-year growth 2024-2029 (%); Exhibits113: Chart on Europe - Market size and forecast 2024-2029 ($ million); Exhibits114: Data Table on Europe - Market size and forecast 2024-2029 ($ million); Exhibits115: Chart on Europe - Year-over-year growth 2024-2029 (%); Exhibits116: Data Table on Europe - Year-over-year growth 2024-2029 (%); Exhibits117: Chart on Asia - Market size and forecast 2024-2029 ($ million); Exhibits118: Data Table on Asia - Market size and forecast 2024-2029 ($ million); Exhibits119: Chart on Asia - Year-over-year growth 2024-2029 (%); Exhibits120: Data Table on Asia - Year-over-year growth 2024-2029 (%); Exhibits121: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million); Exhibits122: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million); Exhibits123: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%); Exhibits124: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%); Exhibits125: Chart on US - Market size and forecast 2024-2029 ($ million); Exhibits126: Data Table on US - Market size and forecast 2024-2029 ($ million); Exhibits127: Chart on US - Year-over-year growth 2024-2029 (%); Exhibits128: Data Table on US - Year-over-year growth 2024-2029 (%); Exhibits129: Chart on China - Market size and forecast 2024-2029 ($ million); Exhibits130: Data Table on China - Market size and forecast 2024-2029 ($ million); Exhibits131: Chart on China - Year-over-year growth 2024-2029 (%); Exhibits132: Data Table on China - Year-over-year growth 2024-2029 (%); Exhibits133: Chart on Canada - Market size and forecast 2024-2029 ($ million); Exhibits134: Data Table on Canada - Market size and forecast 2024-2029 ($ million); Exhibits135: Chart on Canada - Year-over-year growth 2024-2029 (%); Exhibits136: Data Table on Canada - Year-over-year growth 2024-2029 (%); Exhibits137: Chart on Germany - Market size and forecast 2024-2029 ($ million); Exhibits138: Data Table on Germany - Market size and forecast 2024-2029 ($ million); Exhibits139: Chart on Germany - Year-over-year growth 2024-2029 (%); Exhibits140: Data Table on Germany - Year-over-year growth 2024-2029 (%); Exhibits141: Chart on Japan - Market size and forecast 2024-2029 ($ million); Exhibits142: Data Table on Japan - Market size and forecast 2024-2029 ($ million); Exhibits143: Chart on Japan - Year-over-year growth 2024-2029 (%); Exhibits144: Data Table on Japan - Year-over-year growth 2024-2029 (%); Exhibits145: Chart on UK - Market size and forecast 2024-2029 ($ million); Exhibits146: Data Table on UK - Market size and forecast 2024-2029 ($ million); Exhibits147: Chart on UK - Year-over-year growth 2024-2029 (%); Exhibits148: Data Table on UK - Year-over-year growth 2024-2029 (%); Exhibits149: Chart on France - Market size and forecast 2024-2029 ($ million)

Search Inside Report

Pricing

Currency Rates

Single User Online Download $2,500
Global Site License Online Download $4,000

How Do Licenses Work?

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.

Chat Now